What important information is included in the package insert for Fezonatant? How to use this medicine safely according to the instructions?

Fezolinetant is a hormone replacement therapy drug used to treat postmenopausal women. It mainly inhibits the neurokinin NK1R (NK1R) receptor to relieve symptoms caused by fluctuations in hormone levels, especially hot flashes and night sweats. It is a selective, non-hormonal treatment as an alternative to postmenopausal women who may experience discomfort or intolerance to hormone therapy during hormone replacement therapy (HRT). Here is some important information from the label for fezonatant and how patients can use this medicine safely according to the label.

Indications for Fezonatant include the treatment of menopausal symptoms such as hot flashes and night sweats in postmenopausal women. These symptoms are usually related to a decrease in estrogen levels in the body. Fazonatant regulates the activity of neurokinin receptors through non-hormonal mechanisms, reducing symptoms such as hot flashes without causing the common side effects of hormonal drugs, such as an increased risk of breast or endometrial cancer. Fezonatant thus provides an effective and relatively safe alternative for women who are unable or unwilling to use hormonal therapy.

In terms of usage and dosage, Fezonatant is usually taken in the form of oral tablets, and the recommended dose is 45 mg per time once a day. Patients should follow the doctor's advice to choose the appropriate dose and do not increase or decrease the dose at will. Fezonetam can be taken with or on an empty stomach. To ensure optimal effectiveness and reduce side effects, patients are advised to take this medication at the same time every day and continue using it for several weeks or months to evaluate its effectiveness.

Patients must pay special attention to adverse drug reactions when using fezonatant. Common adverse reactions include headache, nausea, diarrhea, loss of appetite, etc. These reactions are usually mild and can gradually alleviate as treatment continues. However, some patients may experience cardiovascular symptoms, such as heart palpitations and high blood pressure. Especially patients with cardiovascular disease or related medical history should use it under the guidance of a doctor and conduct relevant examinations, such as blood pressure monitoring, regularly. In addition, patients should maintain good living habits while using this drug and avoid excessive drinking or taking other drugs that may interfere with the efficacy of the drug.

Contraindications and Precautions: Fezonatant is not suitable for use in pregnant or breastfeeding women because there are insufficient clinical studies to prove its safety to the fetus or infant. For patients with liver damage or severe renal insufficiency, caution should be used when using this drug and the dosage should be adjusted according to the doctor's recommendations. When taking fezonatant, patients should avoid concurrent use of drugs that strongly interact with it, especially CYP3A4 inhibitors or inducers, so as not to affect the metabolism of the drug, thereby affecting its efficacy or causing adverse reactions.

Overall, filazonatant, a novel non-hormonal drug, provides an effective treatment option for hot flashes and night sweats in postmenopausal women. When using this medicine, patients should follow their doctor's advice, take the medicine on time, monitor any possible side effects, and undergo regular physical examinations to ensure the safe use of the medicine. Through rational use of medication, fezonatant can effectively relieve menopausal symptoms and improve patients' quality of life.

Reference materials:https://www.veozah.com/